Scribe Therapeutics SCTX
NASDAQ SCTX
$16.86 -0.50 (-2.88%)
At close: Nov 11, 2026 · 4:00 PM EST

Scribe Therapeutics (SCTX) Net Equity Issued and Repurchased (2026)

Analysis

Scribe Therapeutics (SCTX) Net Equity Issued and Repurchased (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Scribe Therapeutics 43.14 Mn 143,663.76 - 145,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145,000.00
Mar 31, 2026 93,000.00
API Access

Scribe Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SCTX&period=max&api_key=YOUR_API_KEY